Diagnosis of<unk>  may be made based upon a thorough clinical evaluation, detailed patient history, and specialized tests. The World Health Organization (WHO) has set the criteria for diagnosing primary<unk>  (PMF). It has determined set rules for distinguishing the prefibrotic/early (pre-primary<unk>  phase and the overtly fibrotic (overt primary<unk>  phase. The World Health Organization (WHO) has also introduced a proposed revised criteria for primary<unk>  (PMF).
Myelofibrosis diagnostic study of choice
Myelofibrosis other diagnostic studies
Aplastic anemia diagnostic study of choice
Myeloproliferative neoplasm other diagnostic studies
Polycythemia diagnostic study of choice
Chronic myelogenous leukemia diagnostic study of choice
Hairy cell leukemia diagnotic study of choice
Myelofibrosis differential diagnosis